Case report
Cyclosporine-associated central neurotoxicity after heart transplantation

https://doi.org/10.1016/0003-4975(92)91342-7Get rights and content

Abstract

Cyclosporine central neurotoxicity has been described after bone marrow, kidney, and liver transplantation but has not been well documented after heart transplantation. This case illustrates severe reversible neurotoxicity after heart transplantation with characteristic radiographic changes in magnetic resonance imaging.

References (8)

There are more references available in the full text version of this article.

Cited by (24)

  • Long-term cyclosporine A treatment promotes anxiety-like behavior: Possible relation with glutamate signaling in rat hippocampus

    2022, Journal of Affective Disorders Reports
    Citation Excerpt :

    Despite the expected action on the immune system, CsA long-term treatment is associated with adverse effects that have deleterious outcomes on patients’ quality of life and survival (Magnasco et al., 2008). One of the most prominent adverse effects of CsA administration is neurotoxicity, which is responsible for neuropsychological problems, including anxiety, depression, headaches, tremor, hallucinations, and seizures (Batinić et al., 2017; Bechstein, 2000; Martinez, 1998; McManus et al., 1992; Pflugrad et al., 2018; Serkova et al., 2004). However, the clinical predisposition and mechanisms of CsA-induced neurotoxicity remain controversial and poorly understood.

  • Induction and Maintenance of Immunosuppression

    2005, Transplantation of the Liver
  • Cytostatics and immunosuppressive drugs

    1993, Side Effects of Drugs Annual
View all citing articles on Scopus
View full text